Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Surgical Wound Infection 2Neoplasms 2Sepsis 1Rectal Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Inflammation 1Infections 1Febrile Neutropenia 1Emergencies 1Discitis 1Colorectal Neoplasms 1

Interventions

Capecitabine 3Radiotherapy 2Oxaliplatin 2Fentanyl 2Bupivacaine 2udenafil 1sodium phosphate 1oxycodone-acetaminophen 1XELOX 1Tramadol 1Sildenafil Citrate 1Sevoflurane 1Propofol 1Pico-Salax 1Orphenadrine 1Neuroleptanalgesia 1Morphine 1Methadone 1Lidocaine 1Leucovorin 1Ketorolac Tromethamine 1Ketorolac 1Ketamine 1Irinotecan 1Hydromorphone 1Hydrocodone 1Gabapentin 1Fluorouracil 1Ertapenem 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Rectal Neoplasms × Anti-Bacterial Agents × Clear all
NCT04281667 2022-11-17

MOBILE2

Helsinki University Central Hospital

Phase 4 Active not recruiting
604 enrolled
Gastrointestinal

Rectal Neoplasms, Surgical Wound Infection, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡